Our present study suggests that lncRNA XIST knockdown inhibits the stemness properties and tumourigenicity by sponing miR-200c in BCSC-like cells and reveals a potential strategy of targeting XIST for bladder cancer therapy. Here, XIST is linked to urinary bladder cancer.